Substance / Medication

Fenoldopam

Overview

Active Ingredient
fenoldopam
RxNorm CUI
24853

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Fenoldopam for preventing and treating acute kidney injury.
Esezobor Christopher I, Bhatt Girish C, Effa Emmanuel E et al. · Cochrane Database Syst Rev · 2024
PMID: 39607014Meta-AnalysisFull text (PMC)
Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.
Gillies Michael A, Kakar Vivek, Parker Robert J et al. · Crit Care · 2015
PMID: 26703329Meta-AnalysisFull text (PMC)
Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials.
Zangrillo Alberto, Biondi-Zoccai Giuseppe G L, Frati Elena et al. · J Cardiothorac Vasc Anesth · 2012
PMID: 22459931Meta-Analysis
Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
Landoni Giovanni, Biondi-Zoccai Giuseppe G L, Marino Giovanni et al. · J Cardiothorac Vasc Anesth · 2008
PMID: 18249327Meta-Analysis
Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.
Landoni Giovanni, Biondi-Zoccai Giuseppe G L, Tumlin James A et al. · Am J Kidney Dis · 2007
PMID: 17185146Meta-Analysis
Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
O'Hara Jerome F, Mahboobi Ramatia, Novak Steven M et al. · Urology · 2013
PMID: 23374797RCT
Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Cobas Miguel, Paparcuri Gian, De La Pena Maria et al. · Cardiovasc Ther · 2011
PMID: 20955210RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fenoldopam (substance)
SNOMED CT
108590002
UMLS CUI
C0060180
RxNorm CUI
24853

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

3
Conditions
4
Biomarkers
2
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.